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Histone Deacetylase Activity Is Required
for Full Transcriptional Repression by mSin3A
Christian A. Hassig,* Tracey C. Fleischer,² Sin3p interacts with the mSin3 interaction domain, or
SID, in the amino terminus of the four Mad family mem-Andrew N. Billin,² Stuart L. Schreiber,*
and Donald E. Ayer²³ bers (Ayer et al., 1995; Hurlin et al., 1995; Schreiber-
Agus et al., 1995; Kasten et al., 1996). Mad1, Max, and*Howard Hughes Medical Institute
Department of Chemistry and Chemical Biology mSin3A form ternary complexes capable of binding DNA
(Ayer et al., 1995). Point mutations in the SID domainDepartment of Molecular and Cellular Biology
Harvard University of Mad1 disrupt its ability to bind mSin3A, negate its
function as a transcriptional repressor (Ayer et al., 1995),Cambridge, Massachusetts 02138
²Huntsman Cancer Institute and eliminate Mad1 function in several biological assays
(Koskinen et al., 1995; Roussel et al., 1996). These find-Department of Oncological Sciences
Division of Molecular Biology and Genetics ings suggest that Mad:Max heterocomplexes repress
transcription by tethering either mSin3A or mSin3B toUniversity of Utah
Salt Lake City, Utah 84112 DNA. A chimeric protein fusing the SID of Mad1 to the
GAL4 DNA-binding domain results in repression of sim-
ple and complex promoters in a manner that is depen-
dent on mSin3 binding, suggesting that targeting mSin3Summary
to DNA is necessary for repression (Ayer et al., 1996).
Nevertheless, the molecular mechanism(s) for mSin3A-Members of the Mad family of bHLH-Zip proteins het-
mediated repression remain unknown.erodimerize with Max to repress transcription in a se-
Recently, a mammalian histone deacetylase has beenquence-specific manner. Transcriptional repression
by Mad:Max heterodimers is mediated by ternary com- identified, and cDNAs encoding the proteinÐhistone
plex formation with either of the corepressors mSin3A deacetylase 1 or HDAC1 (formerly HD1, renamed HDAC1
or mSin3B. We report here that mSin3A is an in vivo according to GDB Genetic Nomenclature Guide)Ðhave
component of large, heterogeneous multiprotein com- been cloned (Taunton et al., 1996b). HDAC1 is approxi-
plexes and is tightly and specifically associated with mately 60% identical to the S. cerevisiae Rpd3p protein,
at least seven polypeptides. Two of the mSin3A-asso- which is a component of a yeast histone deacetylase
ciated proteins, p50 and p55, are highly related to the complex (Rundlett et al., 1996). Single mutations in either
histone deacetylase HDAC1. The mSin3A immuno- RPD3 or SIN3 give the same phenotypes as RPD3/SIN3
complexes possess histone deacetylase activity that double mutants, suggesting that they function in the
is sensitive to the specific deacetylase inhibitor tra- same pathway (Stillman et al., 1994). Because Mad fam-
poxin. mSin3A-targeted repression of a reporter gene ily proteins use mSin3A as a corepressor and Mad1 can
is reduced by trapoxin treatment, suggesting that his- repress transcription in wild-type yeast but not yeast
tone deacetylation mediates transcriptional repression having a null mutation in SIN3 (Kasten et al., 1996) or
through Mad-Max-mSin3A multimeric complexes. RPD3 (D. J. Stillman, personal communication), it is likely
that themechanism of transcriptional repression by Mad
Introduction proteins may be conserved between yeast and higher
eukaryotes. Consistent with this hypothesis, the DNA-
The Mad family of basic region-helix-loop-helix-leucine binding transcription factor YY1 interacts with a mam-
zipper (bHLH-Zip) proteins plays an important role in malian Rpd3p homolog (mRpd3) to repress transcription
controlling cell proliferation and differentiation (Amati of a heterologous reporter gene (Yang et al., 1996a).
and Land, 1994; Bernards, 1995). Four identified Mad These results demonstrate that mRpd3-like activity
family membersÐMad1, Mxi1, Mad3, and Mad4 (Ayer functions in transcriptional regulation.
et al., 1993; Zervos et al., 1993; Hurlin et al., 1995)Ðform Several lines of evidence suggest that the acetylation
heterodimers with another bHLH-Zip protein, Max, to status of conserved lysines in the amino-terminal do-
repress transcription (Ayer et al., 1993; Hurlin etal., 1995) mains of histones H3 and H4 play a role in the regulation
and are thought to play a negative role in the control of of transcription. In general, histone hyperacetylation
cell proliferation. correlates with transcriptionally active or poised genes;
Two mammalian homologs of the Saccharomyces conversely, hypoacetylation correlates with transcrip-
cerevisiae transcriptional corepressor Sin3p, mSin3A tionally repressed heterochromatin (for reviews, see
and mSin3B, have recently been identified as Mad-inter- Turner, 1993; Loidl, 1994; Wolffe, 1996). While little is
acting proteins and are required for Mad-mediated tran- known about the targeting and regulation of histone
scriptional repression (Ayer et al., 1995; Schreiber-Agus acetyltransferases and deacetylases, it has been re-
et al., 1995). The most conserved regions of these pro- cently shown that several transcriptional coactivators
teins correspond to four putative paired amphipathic possess inherent acetyltransferase activity (Brownell et
helix (PAH) motifs, which have been proposed to consti- al., 1996; Ogryzko et al., 1996) or associate with acetyl-
tute protein±protein interaction surfaces (Wang et al., transferases (Yang et al., 1996b). We report that mSin3A
1990). The second PAH motif in mSin3A, mSin3B, and and HDAC1 associate in vivoand that the histone deace-
tylase inhibitor trapoxin interferes with mSin3A-medi-
ated transcriptional repression.³To whom correspondence should be addressed.
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immunoprecipitates using mSin3A antiserum blocked
with the cognate immunogen, suggesting that the pro-
teins detected are specifically associated with mSin3A.
Furthermore, none of these proteins were detected us-
ing high stringency immunoprecipitation or by Western
blotting of whole-cell lysates using anti-mSin3A, sug-
gesting that they do not share epitopes with mSin3A
and are not proteolytic breakdown products of mSin3A
(data not shown). All of the associated proteins appear
to be present in substoichiometric amounts to mSin3A,
suggesting that mSin3A complexes are heterogeneous.
To test the stability of the mSin3A complex, we sub-
jected low stringency mSin3A immunoprecipitates to
different salt concentrations and ionic detergent condi-
tions. The proteins that remained bound to mSin3A in
the immunocomplex were analyzed by SDS±PAGE. Un-
der the most stringent conditions, we observed only a
slight loss of mSin3A-associated proteins in the immu-
nocomplex (Figure 1B). One exception to this finding
was theapparently quantitative lossof p42 underslightly
elevated salt concentrations. These findings demon-
strate that the mSin3A complex is stable in vivo and
Figure 1. mSin3A Is Present in Cells as a Large Stable Multiprotein suggest that some or all of the mSin3A-associated pro-
Complex teins may facilitate mSin3A function as a transcriptional
Nuclear lysates were prepared from U937 cells metabolically labeled corepressor.
with 35S-methionine and low stringency immunoprecipitations per-
formed with antiserum specific for mSin3A. ``1block'' shows pro-
teins immunoprecipitated when the anti-mSin3A was preincubated HDAC1 and RbAp48 Are Componentswith purified GST-PAH2 (A). In (B), low stringency mSin3A immuno-
of the mSin3A Complexprecipitates were washed for an additional 60 min using the salt
Because Sin3p and Rpd3p appear to function in theand detergent conditions indicated. In (A) and (B), the immunopre-
cipitates were analyzed by SDS±PAGE and autoradiography. Appar- same pathway in yeast and two components of the
ent molecular mass of the coprecipitating proteins and the sizes of mSin3A complex, p50 and p55, are similar in apparent
the molecular mass markers are given in kilodaltons. molecular weight to HDAC1, we hypothesized that
HDAC1 or related proteins might be components of the
mSin3A repressor complex. To test this hypothesis, theResults
proteins bound to mSin3A immunocomplexes were
eluted with ionic detergents and reprecipitated with af-mSin3A Is Present in Cells as a Large Stable
Multiprotein Complex finity-purified antibodies specific for an internal peptide
of HDAC1. Only two of the proteins eluted from theTo study the in vivo function of mSin3A we generated
polyclonal antiserum specific for the PAH2 domain of mSin3A complex were reprecipitated by HDAC1 antise-
rum (Figure 2A). These polypeptides comigrated withmSin3A. We tested this antiserum by immunoprecipita-
tion using nuclear lysates made from the myeloid leuke- p50 and p55 from the low stringency mSin3A immuno-
precipitation, suggesting that proteins highly related tomia cell line U937 that had been metabolically labeled
with 35S-methionine. Analysis of immunoprecipitates HDAC1 are complexed to mSin3A in vivo. The p55 poly-
peptide comigrates with in vitro±translated HDAC1 andshowed an intensely labeled doublet with an apparent
molecular mass of 150 kDa that was present in the anti- is recognized by an antibody specific for a carboxy-
terminal epitope unique to HDAC1. Another cDNA en-mSin3A immunoprecipitates (Figure 1A). This doublet
comigrated with in vitro±translated mSin3A, shared coding an HDAC1 homolog, HDAC2, has recently been
identified (Yang et al., 1996a). It is likely that p50 repre-identical V8 protease digestion profiles with in vitro±
translated mSin3A,and was absent from immunoprecip- sents HDAC2 (data not shown and accompanying pa-
per, Laherty et al., 1997 [this issue of Cell]).itations using preimmune serum or immune serum prein-
cubated with the cognate immunogen (data not shown). In a reciprocal experiment, we performed low strin-
gency immunoprecipitations using antiserum specificFractionation of U937 nuclear extracts by size exclu-
sion chromatography indicated that mSin3A is present for an epitope at the carboxyl terminus of HDAC1.
HDAC1 immunoprecipitates contain several proteinsin large molecular weight complex(es) (D. E. A., unpub-
lished). To address this possibility, we performed immu- that were specifically competed with the immunizing
peptide (Figure 2B). A polypeptide doublet that comi-noprecipitations from metabolically labeled U937 cells
under conditions that should preserve protein±protein grated with mSin3A was detected in the HDAC1 immu-
nocomplexes (Figures 2B and 2C). To confirm that theinteractions. In addition to mSin3A, the low stringency
mSin3A immunoprecipitates contained several labeled doublet coprecipitating with HDAC1 is mSin3A, the
HDAC1 immunocomplex was eluted and reprecipitatedpolypeptides of apparent molecular masses of 250 kDa,
180 kDa, 55 kDa, 50 kDa, 42 kDa, 33±36 kDa, and 30 with antiserum specific for mSin3A (Figure 2C). The two
proteins in this precipitate comigrated with mSin3A,kDa (Figure 1A). These proteins were not detected in
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Figure 2. mSin3A and HDAC1 Associate In Vivo
Immunoprecipitations were performed using nuclear extracts from 35S-methionine-labeled U937 cells. (A) The left lane shows proteins from
an anti-mSin3A immunoprecipitate. The right lane shows proteins eluted from an anti-mSin3A immunoprecipitate and reprecipitated with anti-
serum specific for HDAC1. In (B) and (C), low stringency immunoprecipitations were performed using antiserum specific for the carboxyl
terminus of HDAC1. ``1block'' indicates that the HDAC1 antiserum was preincubated with the immunizing peptide. In (C), proteins immunopre-
cipitated with anti-mSin3A are shown for reference, proteins eluted from a low stringency anti-HDAC1 immunoprecipitate and reprecipitated
with anti-mSin3A are shown in the far right lane. In (A), (B), and (C), autoradiographs of SDS-PAGE gels are shown. Apparent molecular mass
of the coprecipitating proteins and the sizes of the molecular mass markers are given in kilodaltons. In (D), in vitro histone deacetylase activity
in anti-mSin3A immunoprecipitates is shown. Human Jurkat cell extracts (12 mg) were immunoprecipitated using anti-mSin3A polyclonal
antibodies. ``1block'' indicates that the anti-mSin3A antibody was preincubated with GST-PAH2; ``110 nM trapoxin'' indicates that the
immunoprecipitated proteins were pretreated with 10 nM trapoxin for 30 min at 48C prior to being assayed for histone deacetylase activity.
confirming that mSin3A and HDAC1 are associated RbAp48 with mSin3A, we expressed the mammalian
proteins in insect cells using recombinant baculovi-in vivo.
To determine whether HDAC1 associated with mSin3A ruses. To this end, we expressed recombinant FLAG-
epitope-tagged HDAC1 (HDAC1-F), which could bein vivo is enzymatically active, we assayed low strin-
gency immunoprecipitates for histone deacetylase immunopurified by anti-FLAG antibodies, and histidine-
tagged mSin3A (mSin3A-H), which could be purified byactivity. We used a synthetic peptide corresponding to
the first 24 amino acids of histone H4 as a substrate nickel affinity (data not shown). HDAC1-F was immuno-
precipitated from infected Sf9 cell extracts by anti-FLAGfor our deacetylase assay (Taunton et al., 1996b). Low
stringency anti-mSin3A immunoprecipitates contained antibodies in the presence or absence of mSin3A-H.
HDAC1-F was also precipitated by Ni21-NTA agarosedeacetylase activity; however, only background levels
of deacetylase activity were detected in the immunopre- in a manner that was dependent on coexpression of
mSin3A-H (Figure 3B), demonstrating that a complexcipitates if the mSin3A anti-serum was blocked with
cognate immunogen (Figure 2D). To confirm the authen- between HDAC1 and mSin3A is formed in insect cells
using exogenously expressed human proteins.ticity of the mSin3A-associated activity, we treated the
immunoprecipitates with synthetic trapoxin, a specific Consistent with our finding that RbAp48 is associated
with mSin3A and HDAC1 in vivo, we show that baculovi-inhibitor of histone deacetylase activity (Taunton et al.,
1996a). Treatment of mSin3A complexes in vitro with 10 rus-expressed Flu-epitope-tagged RbAp48 (p48-HA) is
specifically precipitated from infected Sf9 cell extractsnM trapoxin reduced deacetylation by approximately
50% (Figure 2D), suggesting that the precipitated de- using anti-FLAG antibody only when HDAC1-F is coex-
pressed. Furthermore, p48-HA is specifically retainedacetylase activity can be attributed to trapoxin-sensitive
histone deacetylases bound to mSin3A. by Ni21-NTA in the presence of mSin3A-H (Figure 3C).
Coexpression of p48-HA did not appear to affect theWe detected an interaction between HDAC1 and
RbAp48 in vivo (Figures 2B and 2C; also Taunton et al., association between HDAC1-F and mSin3A-H, sug-
gesting that the regions of interaction are distinct and1996b). The low stringency mSin3A immunoprecipita-
tion shown in Figure 2C also contained a protein that that all three proteins can associate simultaneously.
These data suggest a direct interaction betweencomigrated with RbAp48 (marked with an asterisk) that
was not readily visible on the shorter exposures of low mSin3A, HDAC1, and RbAp48 in vivo.
stringency mSin3A immunoprecipitations (Figure 2A).
We have identified RbAp48 in mSin3A immunoprecipi- Transcriptional Repression by mSin3A Requires
Histone Deacetylase Activitytates from cell extracts of nontransfected cells by West-
ern blotting, further demonstrating that mSin3A and To investigate whether histone deacetylation plays a
role in mSin3A-mediated transcriptional repression inRbAp48 associate in vivo (Figure 3A).
To address further the association between HDAC1 and vivo, we examined mSin3A-specific repression in the
Cell
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mSin3A, Mad(Pro)N35GALVP16 is a much less potent
repressor (Figure 4B). In control experiments, we have
shown that the observed effects require the presence
of GAL4 sites in the promoter and that both MadN35
GALVP16 and Mad(Pro)N35GALVP16 are expressed to
equivalent levels in these cells and bind GAL4 sites with
similar affinities (data not shown). To test the role of
histone deacetylation on the repression observed in our
transfection assays, we first examined the effect of tra-
poxin on histone deacetylase activity in 293 cells. As
expected, in vivo treatment with 10 nM trapoxin for 8 hr
reduced deacetylase activity of both crude 293 extracts
and anti-HDAC1 immunopurified complexes by approxi-
mately 46% and 58%, respectively (Figure 4C).
To test the effect of a histone deacetylase inhibitor
on MadN35GALVP16- and Mad(Pro)N35GALVP16-
mediated repression, we treateda duplicate set of trans-
fections with 10 nM trapoxin for 8 hr prior to harvest. In
the representative experiment shown, 10 nM trapoxin
treatment derepressed the activity of MadN35GALVP16
9-fold while it had little effect on the activity of Mad-
(Pro)N35GALVP16, suggesting that histone deacetyla-
tion plays a direct role in mSin3A transcriptional repres-
Figure 3. RbAp48 Is Associated with mSin3A In Vivo and Recombi- sion (Figure 4B). In addition, there was typically less
nant HDAC1, RbAp48, and mSin3A Copurify from Insect Cell Ex- than a 2-fold effect of trapoxin on the activity of the
tracts
reporter gene in cells transfected with the expression
(A) TAg Jurkat cell lysates were immunoprecipitated using antibod-
vector alone or in cells transfected with GALVP16 (dataies specific to the C-terminal portion of HDAC1 (left) or antibodies
not shown). Following trapoxin treatment, the repressionspecific to PAH2 of mSin3A (right). Parallel immunoprecipitations
observed for MadN35GALVP16 was still seven timeswere blocked as described in Figure 2. Immunopurified proteins
were analyzed by SDS±PAGE and immunoblotted with a-RbAp48 greater than that of Mad(Pro)N35GALVP16, suggesting
monoclonal antibody 12B1. that the residual deacetylase activity following trapoxin
(B and C) Equal amounts of baculovirus-coinfected Sf9 cell extracts treatment (Figure 4B) continues to drive mSin3A-medi-
were affinity purified using Ni21-NTA-agarose (Ni) or a-FLAG-M2-
ated repression; however, we can not rule out thatagarose (F). Purified recombinant proteins were analyzed by SDS±
mSin3A is capable of repression by mechanisms inde-PAGE, transferred to Immobilon-P (Millipore) and immunoblotted
pendent of histone deacetylation.with a-FLAG to detect HDAC1-F (B) or a-Flu (12CA5) to detect p48-
HA (C). We observe a reduction in expression of HDAC1-F and p48-
HA when coexpressed with mSin3A.
Discussion
Earlier studies implicated mSin3 as the primary candi-presence and absence of the histone deacetylase inhibi-
tor trapoxin. Human 293 cells were transfected with a date responsible for the negative transcriptional func-
tion of the DNA-binding transcription factor Mad (Ayerluciferase reporter gene construct containing a minimal
promoter consisting of only a TATA box and initiation et al., 1995; Schreiber-Agus et al., 1995; Ayer et al.,
1996). We present evidence that the mSin3A corepres-site derived from the myelomonocytic growth factor
gene (Figure 4A). This reporter has four consensus bind- sor is part of a high molecular weight, multicomponent
complex(es) that contains active histone deacetylase,ing sites for the DNA binding domain of the S. cerevisiae
transcriptional activator GAL4 and therefore is respon- thereby implicating histone deacetylation as a potential
mechanism for mSin3A-mediated repression. Further-sive to chimericproteins containing the GAL4 DNA bind-
ing domain (GALDBD) (Sterneck et al., 1992). We have more, we observe a pronounced increase in the tran-
scriptional activity of an mSin3A-silenced reporter geneused this reporter construct previously to demonstrate
that fusion of the SID repressor region of Mad1 to the upon treatment in vivo with the specifichistone deacety-
lase inhibitor trapoxin, suggesting that full transcrip-GALDBD is necessary for mSin3A-dependent transcrip-
tional repression. Furthermore, we have shown that fu- tional repression by mSin3A requires histone deace-
tylation. These results suggest a mechanism of genesion of SID to the potent transcriptional activator
GALVP16, MadN35GALVP16, can cancel the activation regulation through the targeting of an enzyme that alters
chromatin structure.function of VP16 in an mSin3A-dependent manner. Con-
sistent with our previous results (Ayer et al., 1996), Mad- These observations areconsistent with genetic exper-
iments in yeast, suggesting that the yeast orthologs ofN35GALVP16 activated transcription from the reporter
gene approximately 100-fold less well than GALVP16 mSin3A and HDAC1, Sin3p and Rpd3p, respectively, are
epistatic transcriptional regulators (Stillman et al., 1994).(data not shown). As a negative control, we engineered
two proline substitutions into the SID of Mad1; this Mad- Furthermore, recent biochemical evidence demon-
strates that Rpd3p is a component of a large molecular(Pro) protein cannot bind mSin3A in vitro (Ayer et al.,
1995). Consistent with an inability to interact with weight histone deacetylase complex in yeast (Rundlett
mSin3A Corepressor Complexes
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reporter genes. The MadN35GALVP16 chimera func-
tioned as a repressor by a mechanism that was depen-
dent on the binding of mSin3A and that was sensitive
to trapoxin. The same mutations that inactivate MadN3-
5GALVP16 as a transcriptional repressor (i.e., Mad-
(Pro)N35GALVP16), also block interaction between
Mad1 and mSin3A in vitro and Mad1 function in vivo.
Therefore, it is likely that Mad:Max heterocomplexes
repress transcription in a manner dependent on an
mSin3A-associated histone deacetylase.
By coimmunoprecipitation, we have demonstrated
that mSin3A and HDAC1 associate in vivo. Consistent
with these data, we observed nuclear colocalization of
mSin3A and HDAC1 by immunofluorescence micros-
copy (data not shown). Finally, overexpression in insect
cells facilitates copurification of mSin3A and HDAC1
(Figures 3B and 3C), suggesting that the interaction be-
tween mSin3A and HDAC1 is either direct or requires a
conserved cofactor. The finding that mSin3A has differ-
ent associated histone deacetylases (HDAC1 and
HDAC2) suggests that the mSin3A complex(es) may
have multiple substrate or target specificities. The het-
erogeneous nature of the mSin3A complex potentially
reflects a diverse array of repressors, histone deacety-
lases, and different targeting molecules that facilitate
mSin3A-dependent alterations in gene expression.
At least five additional polypeptides, whose functions
are currently unknown, are stably associated with
mSin3A (Figures 1 and 2), but tight association with
mSin3A in both U937 cells and Jurkat T cells (data not
shown) suggests that they in some way mediate mSin3A
function. Furthermore, we have identified an association
between mSin3A and RbAp48 in vivo, suggesting that
Figure 4. Trapoxin Reverses Transcriptional Repression by mSin3A this protein may play a role in regulating mSin3A-tar-
(A) The structure of the minimal reporter gene derived from the geted deacetylation. RbAp48 was originally identified
myelomonocytic growth factor gene and the expression vectors. as a retinoblastoma-binding protein that contains WD
Mad(Pro)N35GALVP16 has leucine at position 12 and alanine at repeats and shares homology with the b subunit of G
position 16 mutated to proline as indicated. These point mutations proteins (Qian et al., 1993). Subsequently, it has beenprevent association between mSin3A and Mad (Ayer et al., 1995).
shown that RbAp48 or its orthologs are involved in tar-(B) The transcriptional activity of MadN35GALVP16 and Mad(Pro)N-
geting different histone modifying enzymes tochromatin35GALVP16 was determined by measuring luciferase activity (rela-
tive light units, RLU) of transfected 293 cells following an 8 hr treat- (Parthun et al., 1996; Taunton et al., 1996b; Tyler et
ment with 0 (closed bars) or 10 nM trapoxin (striped bars). To control al., 1996; Verreault et al., 1996). The mSin3A/RbAp48
for differences in transfection efficiency, the RLU values were nor- complex isolated from U937 cells (Figure 2) is likely to
malized to the b-galactosidase activity produced by a cotransfected represent only a small fraction of themSin3A complexes,
CMV-bGAL construct. Shown is data from a representative experi-
but its detection implies that mSin3A may play a role inment, and the error (SEM). This experiment has been done a mini-
the control of different aspects of chromatin physiologymum of five times in triplicate with similar results. An 8 hr treatment
of 293 cells with 10 nM trapoxin is within the linear range of the as well as transcriptional repression.
response of the reporter gene. Furthermore, trapoxin treatment did It is unclear how different chromatin states facilitate
not prevent association between mSin3A and HDAC1 (data not transcriptional repression and activation or how their
shown). distinct biochemical states arise; however, there is
(C) Trapoxin inhibits histone deacetylase activity of human 293 cells
ample cytological, genetic, and biochemical evidencein vivo. Cells (2 3 108) were cultured for 8 hr in the absence (0) or
supporting the model that hyperacetylated chromatin isin the presence of (10) 10 nM trapoxin. Cells were harvested and
transcriptionally more active than hypoacetylated chro-crude extracts from approximately 1 3 107 cells (closed bars) or
anti-HDAC1 immunoprecipitations of extracts from approximately matin. Acetylation levels in b-heterochromatin of Dro-
4 3 107 cells (open bars) were assayed for histone deacetylase sophila melanogaster polytene chromosomes are signif-
activity in vitro. icantly reduced at lysine positions 5, 8, and 16 of histone
H4, while the transcriptionally hyperactive X chromo-
some of male flies is uniquely hyperacetylated at posi-
et al., 1996). Together with our results, these findings tion 16 (Turner et al., 1992). In yeast, mutation of acetyl-
predict a conservation of the mSin3/HDAC1 functional accepting lysines in histone H4 reduces the activity of
association in yeast. the GAL1, PHO5, and CUP1 promoters in vivo (Durrin
We have used chimeric transcriptional regulators to et al., 1991). The transcriptionally silent regions in yeast,
HML and HMR, are hypoacetylated, and their activationdiscern the effects of trapoxin on the activity of our
Cell
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ng CMV-b-gal, 50 ng expression construct, and 2.85 mg carrier DNAis correlated with acetylation of histone H4 (Braunstein
using the BBS/CaPO4 method. Trapoxin was added to 10 nM 8 hret al., 1993). Additionally, biochemical studies showed
prior to the luciferase assays. Cell lysates were prepared 20±24 hrthat certain transcription factors have higher affinity for
following transfections, and luciferase and b-galactosidase activi-
their binding sites when those sites are embedded in ties were assayed according to manufacturers' directions (Promega,
chromatin assembled from hyperacetylated histones Tropix). Luciferase values (relative light units) were normalized for
transfection efficiency by dividing by b-gal activity.(Lee et al., 1993; Vettese-Dadey et al., 1996). Finally,
evidence suggesting that acetylation is required for acti-
Histone Deacetylase Assaysvation comes from therecent demonstration that several
In vitro histone deacetylase activity was assayed essentially as de-coactivators are acetyltransferases or are associated
scribed with either 50 ml of crude cell extract (approximately 5 3
with acetyltransferases. Thus, our datasupport this gen- 106 cells) or immunopurified cell extracts (approximately 2 3 107
eral model for the control of gene expression by histone cells) for 2.5 hr at 378C (Taunton et al., 1996b). Pretreatment of crude
acetylation status and provide a biochemical mecha- or immunopurified extract with synthetic trapoxin was performed
for 30 min at 48C prior to addition of peptide substrate. TAg Jurkatnism for deacetylation-mediated repression.
and 293 cell extracts for histone deacetylase assays were preparedThe acetylation status of a particular chromatin region
as in Taunton et al., 1996b. Anti-HDAC1 and anti-mSin3A immuno-represents a balance between competing acetylation
precipitations were performed as described above and in Figure 2.
and deacetylation reactions. We propose that MadN35- The Protein A±conjugated immunoprecipitates were washed three
GALVP16 recruits mSin3A±HDAC complexes to specific times in J buffer plus 1 mM EDTA and resuspended in J buffer
sites on DNA and shifts this equilibrium toward deacety- without Triton X-100, and histone deacetylase activity was mea-
sured as described.lation and subsequent transcription repression by creat-
ing a high effective molarity of the histone deacetylase.
BaculovirusesIn yeast, the activation domain of VP16 has been shown
cDNAs encoding FLAG-tagged HDAC1, HA-tagged RbAp48, andto use the acetyltransferase Gcn5p as a coactivator
His-tagged mSin3A were cloned into the transfer vector pVL1392
(Marcus et al., 1994; Brownell et al., 1996), suggesting (specific details on the construction of these vectors are available
that in mammalian cells VP16 will also use an acetyl- upon request). Recombinant virus was generated using Baculogold
transferase as a cofactor. Thus, trapoxin treatment DNA according to the manufacturer's instructions (Pharminigen).
Sf9 or High 5 cells were infected at high multiplicity, extracts pre-could shift the equilibrium from deacetylation to acetyla-
pared 48 hr postinfection, and immunoprecipitations performed astion and thereby drive activation.
described above. Ni21-NTA agarose and anti-FLAG antibody wereWhether histone deacetylation will always have a neg-
purchased from Qiagen and Kodak-IBI, respectively.
ative effect on gene expression is unclear. Mutants in
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